Terapin

Private

SeoulMedia, Entertainment & Gaminghttps://copinwebtoon.com/

Last Round

Private Equity

Aug 1, 2022

Est. Valuation

$58.62M

Total Funding Raised

$167.66M

Company Overview

Terapin is a digital content company that specializes in the production, distribution, and monetization of webtoons, web novels, and character intellectual property.

Sector

Media, Entertainment & Gaming

Verticals

Content Creation, Digital Publishing, Streaming Platforms, Creator Economy

Business Model

B2C

Customer Profile

Subscription SaaS, Revenue Share, Freemium

AI Layer

Application

Keywords

webtoonweb noveldigital comicsone-source-multi-useOSMUIP licensingwebtoon platformcontent productioncharacter brandingemoticon designmanhwadigital content distributionsubscription serviceAI-assisted contentwebtoon studio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Terapin Comps

Public and private peers based on sector, stage, and business model.

Terapin comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Terapin Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	Aug 1, 2022
Private Equity	Jan 14, 2022
VC Round	Sep 14, 2021
Series B	Apr 21, 2021
Series A Extension	Jun 21, 2020
Series A	Nov 13, 2019

View all Funding Rounds

Terapin Investors

Notable investors and investment history

Terapin investors
Investor	Rounds
DA Value Investment	Series A Extension, Series A
Hyundai Investment Partners	Series B, Series A Extension, Series A
KB Investment	Series B, Series A Extension, Series A
NPX Capital	Private Equity
Wonik Investment Partners	Series B, Series A Extension
Affirma Capital	Private Equity
NPX Capital	VC Round

View all Investors

Terapin Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Terapin Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Terapin's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Year Founded2014

Last FundingAug 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.